CAR-MSC 的最新进展:细胞免疫治疗演化的新引擎
Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution.
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Recent advances in CAR-MSCs: the new engine of cellular immunotherapy evolution.
B7-H3 in Cancer Immunotherapy-Prospects and Challenges: A Review of the Literature.
Unconventional T cells in anti-cancer immunity.
An update on the clinical trial research of immunotherapy for glioblastoma.
Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1.
Cancer Stem Cell-targeted Antibody-drug Conjugates for Cancer Immunotherapy.
Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.
Bispecific T-cell engagers for the recruitment of T cells in solid tumors: a literature review.
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
MEMBER ACCOUNT
登录成功会直接打开下一页。